Skip to main content
News Archive

GSK jumps into Zika vax hunt on heels of Sanofi’s deal – FiercePharma

By July 11, 2016May 22nd, 2025No Comments

GlaxoSmithKline-gsk-logo

After months of work under the radar, GlaxoSmithKline committed to entering the Zika R&D field, announcing on Thursday that it’s pairing with the National Institutes of Health in a project based at its new vaccine research hub in Rockville, MD.

{iframe}http://www.fiercepharma.com/pharma/gsk-enters-zika-vaccine-scene-nih-collaboration{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.